arrow
D

David A. Palma

London Health Sciences Centre
H指数:66
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer

理解和克服未分化甲状腺癌中MAPK抑制的固有和获得性耐药性

2026-05-150
OAAI
The SHARE study - Survivorship After Head and Neck Cancer: evaluating patient care and adherence to follow up in Ontario, Canada: study protocol for a randomized controlled trial

SHARE研究——头颈癌幸存者生存状况:评估加拿大安大略省的患者护理和随访依从性:一项随机对照试验的研究方案

2025-12-130
PRE
NOTCH1 loss promotes chemo and radio-resistance in head and neck cancer

NOTCH1缺失促进头颈癌的化疗和放疗抗性。

2025-12-080
PRE
Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial

立体定向放射治疗早期非小细胞肺癌合并间质性肺疾病患者的剂量学结局:ASPIRE-ILD试验的二次分析

2025-09-290
PRE
Dosimetric Outcomes of SBRT to Ultra-central Lung Tumors: Lessons from the SUNSET trial

SBRT治疗超中心型肺癌的剂量学结果:SUNSET试验的经验

2025-09-030
OAAI
Enhancing Opportunities for Resident-Supervised Medical Student Research: A Seven-Year Evaluation of the Oncology Research Internship (ORIoN)

提升由住院医师指导的医学生科研机会:一项关于肿瘤学研究实习项目(ORIoN)的七年评估

2025-08-130
PRE
Treatment Toxicity and Outcomes Following Definitive Radiation Therapy for Patients With Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease—A Systematic Review and Dosimetric Analysis

早期非小细胞肺癌合并预存间质性肺疾病患者接受根治性放射治疗后的治疗毒性及预后结果——一项系统评价和剂量学分析

2025-06-270
PRE
International Patterns of Practice for SABR for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?

早期非小细胞肺癌SBRT的国际实践模式:我们是否步调一致?

2025-04-290
PRE
Opioid therapy vs. Multimodal analgesia in head and neck cancer (OPTIMAL-HN): Results of a randomized clinical trial
2025-03-010
PRE
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
2025-01-012
PRE
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical Outcomes
2025-01-010
OAAI